A clinical trial is a research study designed to evaluate potential new treatment options by testing the safety and effectiveness of new or modified cancer drugs, new drug doses, unique approaches to surgery or radiation therapy and varied combinations of treatments.
(Follow the link below each trial for more information)
A randomized phase III trial of Palbociclib with standard adjuvant endocrine therapy versus standard adjuvant endocrine therapy alone for hormone receptor positive (HR+) / human epidermal growth factor receptor 2 (HER2)-negative early breast cancer.
A randomized, double-blind, placebo-controlled phase 2 study of paclitaxel in combination with Reparixin compared to paclitaxel alone as front-line therapy for Metastatic Triple-Negative Breast Cancer (FRIDA)
A Randomized Phase III Post-Operative Trial of Platinum Based Chemotherapy Vs. Observation in Patients with Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)- Women of Asian ethnicity only
A Randomized, Double-Blind, Phase III Study of Platinum+ Pemetrexed Chemotherapy with
or without Pembrolizumab (MK-3475) in First Line Metastatic Non-squamous Non-small
Cell Lung Cancer Subjects (KEYNOTE-189)
For further information locally contact firstname.lastname@example.org